Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX

  1. Spencer, A.
  2. Moreau, P.
  3. Mateos, M.-V.
  4. Goldschmidt, H.
  5. Suzuki, K.
  6. Levin, M.-D.
  7. Sonneveld, P.
  8. Orlowski, R.Z.
  9. Yoon, S.-S.
  10. Usmani, S.Z.
  11. Weisel, K.
  12. Reece, D.
  13. Ahmadi, T.
  14. Pei, H.
  15. Mayo, W.G.
  16. Gai, X.
  17. Carey, J.
  18. Bartlett, J.B.
  19. Carson, R.
  20. Dimopoulos, M.A.
Journal:
Blood Advances

ISSN: 2473-9537 2473-9529

Year of publication: 2024

Volume: 8

Issue: 2

Pages: 388-398

Type: Article

DOI: 10.1182/BLOODADVANCES.2023010579 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals